Precision Medicine in Oncology

Number of Personalized Medicines Doubled in 4 Years, New Report Says

December 28th 2020, 2:00pm

Article

A report published by the Personalized Medicine Coalition shows that the number of personalized medicines on the market grew at the highest rate ever recorded by the organization from 2016-2020.

Dr Michael Korn Highlights a Key Takeaway From the Precision Medicine Session at QCCA’s Fall Meeting

December 27th 2020, 3:00pm

Video

During the panel on precision medicine at the Quality Cancer Care Alliance (QCCA) Fall Leadership Summit, the speakers discussed testing every patient upfront with a broad molecular assessment and bringing clinical research to the patient.

The Top 5 Most-Read Precision Oncology Articles of 2020

December 27th 2020, 11:30am

Article

A top-5 roundup of some of 2020's advancements in the precision oncology space.

PMC Report Shows Number of Personalized Medicines Doubled in 4 Years

December 22nd 2020, 7:40pm

Article

A report published by the Personalized Medicine Coalition (PMC) shows that the number of personalized medicines on the market is growing at the highest rate ever recorded by the organization.

Managing the “Knowledge Explosion” a Key Challenge of Precision Oncology

December 20th 2020, 11:00am

Article

Managing the constantly evolving selection of therapies in oncology can be difficult, but is of the utmost importance to get the right treatment to the right patient, agreed a panel at Patient-Centered Oncology Care® 2020.

Duplex Sequencing Technology Detects Early Carcinogen-Caused Mutagenesis

December 18th 2020, 10:00pm

Article

A new study validates the application of duplex sequencing in detecting mutations caused by chemical carcinogens.

From Making Oncology Clinical Pathways Multidisciplinary, to Adding the Patient’s Voice

December 18th 2020, 11:00am

Article

According to the final panel at Patient-Centered Oncology Care®, clinical pathways can create a new problem: if each payer tries to impose its own pathways, it’s an administrative and ethical nightmare.

Dr Michael Korn Outlines the Collaborative Nature of the Caris Precision Oncology Alliance

December 13th 2020, 2:30pm

Video

The Caris Precision Oncology Alliance has brought together academic institutions and community practices with the goal of performing research and exchanging evidence and ideas for new types of tests, said W. Michael Korn, MD.

Creating Personalized Immunotherapy in Large B-Cell Lymphoma

December 12th 2020, 7:45pm

Article

The findings help explain why costly CAR T-cell therapy does not work for some patients.

Clinical Data Show Patient, Cost Benefits of MRD Testing in Multiple Myeloma

December 7th 2020, 7:30pm

Article

Data presented at the 62nd Annual ASH Meeting demonstrated the clinical utility of Adaptive Biotechnologies’ clonoSEQ next-generation sequencing to detect MRD in multiple myeloma patients.